Emergent BioSolutions: Pay

Emergent BioSolutions paid its 5 named executives $12.6M in total in FY2025 (Dec). CEO Joseph Papa was paid $5.3M of that.

PayNo stock prices for these years

CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

Joseph PapaPresident, Chief Executive Officer and Director


FY2025 (Dec)
FY2024 (Dec)

2 years

Richard LindahlExecutive Vice President, Chief Financial Officer


FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)							Not disclosed
FY2021 (Dec)							Not disclosed

5 years

Coleen GlessnerExecutive Vice President, Quality and Ethics and Compliance


FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)

3 years

Simon LowryChief Medical Officer and Head of Research and Development


FY2025 (Dec)

1 year

Paul WilliamsSenior Vice President, Products Business


FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)

3 years

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.